Navigation Links
Transplanted neural stem cells slows als onset and progression in mouse models
Date:12/19/2012

WORCESTER, MA Promising new research provides evidence that ALS, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be treatable using neural stem cells. A consortium of researchers at multiple institutions, including the University of Massachusetts Medical School, Sanford-Burnham Medical Research Institute and Brigham and Women's Hospital, have shown that neural stem cells, when transplanted into the spinal cord of a mouse model with familial ALS, slow disease onset and progression while improving motor function, breathing and survival time compared to untreated mice. A summary of the studies was published online in Science Translational Medicine.

ALS is a progressive, neurodegenerative disorder affecting the motor neurons in the central nervous system. As motor neurons die, the brain's ability to send signals to the body's muscles is compromised. This leads to loss of voluntary muscle movement, paralysis and eventually respiratory failure. The cause of most cases of ALS is not known.

Approximately 10 percent of cases are inherited. Though investigators at UMass Medical School and elsewhere have identified several genes shown to cause inherited or familial ALS, almost 50 percent of these cases have an unknown genetic cause.

Neural stem cells are the precursors of all brain cells. They can self-renew, making more neural stem cells, and differentiate, becoming nerve cells or other brain cells. These cells can also rescue malfunctioning nerve cells and help preserve and regenerate brain tissue. But they've never before been studied extensively in a good model of adult ALS.

In 11 independent studies, the group, headed by Dr. Evan Snyder of the Burnham Institute, transplanted neural stem cells into the spinal cord of a mouse model of ALS. The transplanted neural stem cells benefited the mice with ALS by preserving the health and function of the remaining nerve cells.

Specifically, the
'/>"/>

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2

Related biology news :

1. New cranial neural crest cell line developed
2. New neural pathway controlling skeletal development discovered
3. Astrocytes control the generation of new neurons from neural stem cells
4. Novel microscopy method offers sharper view of brains neural network
5. Color-coded markers may help doctors diagnose neural diseases through the eyes
6. Transgenic technique to eliminate a specific neural circuit of the brain in primates
7. Manipulation of a specific neural circuit buried in complicated brain networks in primates
8. Cracking the Neural Code: Third Annual Aspen Brain Forum
9. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
10. Scientists find neural stem cell regulator
11. Protein creates paths for growing nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014Women in the West African nation Burkina ... planning option. Sayana Press has the potential to ... the health system and in communities by combining ... Depo-Provera (depot medroxyprogesterone acetate)with the BD Uniject injection ... four African countries expected to begin introducing Sayana ...
(Date:7/9/2014)... Caesarean section have a different intestinal flora than children delivered ... is the case and what it means for the immune ... therefore decided to scrutinise the impact of birth on the ... mouse pups. , The study shows that ... of cells that strengthen the immune system, says Camilla Hartmann ...
(Date:7/9/2014)... hunts in Indiana state parks have helped restore the ... by overabundant populations of white-tailed deer, a Purdue study ... associate professor of forest ecology, found that a 17-year-long ... in state parks has successfully spurred the regrowth of ... browsing deer. , Jenkins said that while hunting ...
Breaking Biology News(10 mins):Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3Mouse study: Natural birth may strengthen the immune system 2Hunting gives deer-damaged forests in state parks a shot at recovery 2
... in the Canadian Rockies are stifling the mating choices ... researchers. , Smaller and less abundant alpine meadows--largely the ... pool, creating a pattern that could lead to the ... Roland, a biological scientist at the University of Alberta ...
... and bitter tastes may reside in the same taste bud ... discovery of a chemical messenger called neuropeptide Y (NPY) in ... is active in the brain and gut, this is the ... taste bud cells. , That finding gives scientists a deeper ...
... which is involved in cellular immune signaling, scientists have succeeded ... This old protein with a new twist may eventually be ... Stat1 is involved in immune responses that are initiated by ... cells of the immune system in response to challenges by ...
Cached Biology News:Expanding forests darken the outlook for butterflies, study shows 2Bitter or sweet? The same taste bud can tell the difference 2Bitter or sweet? The same taste bud can tell the difference 3Engineered molecule amplifies body's immune response 2Engineered molecule amplifies body's immune response 3
(Date:1/14/2014)... Jan. 14, 2014  3D Communications, a leading provider of strategic communications ... and media events in the United States ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as ...
(Date:1/14/2014)... DIEGO and BETHESDA, Md. ... are joining together with two institutes from the National ... reliable tools for bringing safer, more effective treatments to ... the National Center for Advancing Translational Sciences (NCATS) and ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 During the ... now known as “The Doctor’s Plague.” In this time period, ... hands. This led, at times, to the death of vulnerable ... today don’t know that they may be unwittingly transmitting herpes ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... 2011 CryoLife, Inc. (NYSE: CRY ), an ... today that it has filed an IDE with ... clinical trials for the purpose of obtaining Pre-Market Approval (PMA) ... surgical procedures or following traumatic injuries. PerClot ...
... 2011 Orexigen ® Therapeutics, Inc. (Nasdaq: ... showed that overweight and obese patients treated with ... 24-hour circadian patterns over one year of treatment. ... monitoring (ABPM) sub-study of the COR-II trial that ...
... OMER ), a biopharmaceutical company committed to ... and disorders of the central nervous system, today announced ... officer, is scheduled to present at the 10th Annual ... this week.  The presentation is scheduled for Tuesday, April ...
Cached Biology Technology:CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 2CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 3CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 4Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 2Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 3Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring 4
...
... T4 DNA Ligase catalyzes the formation ... ATP between double-stranded DNAs with 3' hydroxyl ... DNA Ligase buffer optimizes ligation which can ... nucleic acids are not substrates for this ...
Bovine Renal Artery Smooth Muscle Cells (BRASMC) (>500,000 cells)...
... The Finnpipette BioControl is a ... technology. A complete liquid handling system ... twelve interchangeable tip cone modules. All ... tip cone modules fit one handle. ...
Biology Products: